These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29277937)

  • 1. Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.
    Scaglione A; Monteonofrio L; Parisi G; Cecchetti C; Siepi F; Rinaldo C; Giorgi A; Verzili D; Zamparelli C; Savino C; Soddu S; Vallone B; Montemiglio LC
    Protein Sci; 2018 Mar; 27(3):725-737. PubMed ID: 29277937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop.
    Saul VV; de la Vega L; Milanovic M; Krüger M; Braun T; Fritz-Wolf K; Becker K; Schmitz ML
    J Mol Cell Biol; 2013 Feb; 5(1):27-38. PubMed ID: 23000554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.
    Siepi F; Gatti V; Camerini S; Crescenzi M; Soddu S
    Biochim Biophys Acta; 2013 Jun; 1833(6):1443-53. PubMed ID: 23485397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
    van der Laden J; Soppa U; Becker W
    Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.
    Agnew C; Liu L; Liu S; Xu W; You L; Yeung W; Kannan N; Jablons D; Jura N
    J Biol Chem; 2019 Sep; 294(37):13545-13559. PubMed ID: 31341017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
    Sung KS; Go YY; Ahn JH; Kim YH; Kim Y; Choi CY
    FEBS Lett; 2005 Jun; 579(14):3001-8. PubMed ID: 15896780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
    Gresko E; Möller A; Roscic A; Schmitz ML
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation.
    Verdina A; Di Rocco G; Virdia I; Monteonofrio L; Gatti V; Policicchio E; Bruselles A; Tartaglia M; Soddu S
    Oncotarget; 2017 Mar; 8(10):16744-16754. PubMed ID: 28060750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2.
    Müller JP; Scholl S; Kunick C; Klempnauer KH
    Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118894. PubMed ID: 33091504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest.
    Giraud S; Diaz-Latoud C; Hacot S; Textoris J; Bourette RP; Diaz JJ
    J Virol; 2004 Mar; 78(6):2984-93. PubMed ID: 14990717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
    Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
    Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.
    Akaike Y; Kuwano Y; Nishida K; Kurokawa K; Kajita K; Kano S; Masuda K; Rokutan K
    Oncogene; 2015 Jun; 34(26):3463-73. PubMed ID: 25151962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
    Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
    Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
    Ohtsu N; Nobuhisa I; Mochita M; Taga T
    Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.
    Hashimoto K; Tsuji Y
    J Mol Biol; 2017 Jan; 429(1):64-78. PubMed ID: 27884605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
    Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
    Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.